Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche launches US$5.75bn bond to back InterMune deal -lead
Yahoo/Reuters
Monday, September 22, 2014 - 3:43pm
tags:
Roche, InterMune, M&A
Gilead Sciences: A Preview of Important HIV Drug Study Results
TheStreet.com
Monday, September 22, 2014 - 2:48pm
tags:
Gilead Sciences, HIV, tenofovir
3 Partnerships Pushing The Pharmaceutical Sector Forward
Yahoo/Benzinga
Monday, September 22, 2014 - 2:46pm
tags:
AbbVie, Infinity Pharmaceuticals, Clevexel Pharma, Guilin Pharmaceutical, The Chiesi Group, Pappas & Associates
3 Stocks Pulling The Drugs Industry Downward
TheStreet.com
Monday, September 22, 2014 - 2:42pm
tags:
AbbVie, Pfizer, Gilead Sciences
GlaxoSmithKline, Avalon launch a pair of new build-to-buy biotechs
Fierce Biotech
Monday, September 22, 2014 - 12:50pm
tags:
GSK, biotech, Avalon Ventures, Silarus Therapeutics, Thyritope Biosciences
An Eisai Special? Bill Would Speed DEA Listings for Controlled Substances
WSJ Pharmalot
Monday, September 22, 2014 - 12:09pm
tags:
Eisai, DEA, controlled substances
FDA authorizes emergency use of Tekmira's Ebola treatment
Reuters
Monday, September 22, 2014 - 10:09am
tags:
Tekmira Pharmaceuticals, ebola virus, FDA
TauRx hits milestone in mild Alzheimer's trial
Pharmaphorum
Monday, September 22, 2014 - 10:00am
tags:
TauRx, Alzheimer's disease, LMTX
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Monday, September 22, 2014 - 9:56am
tags:
Zytiga, Xtandi, JNJ, prostate cancer, Medivation, Astellas
Did Boston Scientific lose $74M mesh trial over an email?
Mass Device
Monday, September 22, 2014 - 9:54am
tags:
Boston Scientific, devices, pelvic mesh
House passes bill to repeal, refund medical device tax
Mass Device
Monday, September 22, 2014 - 9:53am
tags:
devices, device tax
Regeneron touts its allergy drug as a blockbuster in waiting
Fierce Biotech
Monday, September 22, 2014 - 9:37am
tags:
Regeneron, allergy, alirocumab, dupilumab
Infographic – Can Eli Lilly turn up the competitive heat in diabetes?
First Word Pharma
Monday, September 22, 2014 - 9:30am
tags:
Eli Lilly, diabetes, Trulicity, GLP-1 agonist
Gilead’s Zydelig And Johnson & Johnson-Pharmacyclic’s Imbruvica Fighting To Lead Anti-Cancer Drug Race
Bidness Etc.
Monday, September 22, 2014 - 8:36am
tags:
Gilead Sciences, JNJ, Pharmacyclics, Imbruvica, Zydelig
Auxilium Pharma rejects Endo's takeover offer; said it 'significantly undervalues' its business
Yahoo/AP
Monday, September 22, 2014 - 8:09am
tags:
Endo Health Solutions, Auxilium, M&A
Young Physicians OK With Obamacare While Older Doctors Bristle
Forbes
Monday, September 22, 2014 - 8:06am
tags:
physicians, Affordable Care Act
How Should Foreign Companies Interpret GSK's China Fines And Penalties?
Forbes
Monday, September 22, 2014 - 8:04am
tags:
GSK, China, bribery
[video]Merck KGaA to acquire Sigma-Aldrich for $17 billion
CNBC
Monday, September 22, 2014 - 8:01am
tags:
Merck KGaA, M&A, Sigma-Aldrich
Horizon Pharma moves to Ireland to avoid high US taxes
Market Business News
Sunday, September 21, 2014 - 10:48am
tags:
Horizon Pharma
InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action
Yahoo/PR Newswire
Sunday, September 21, 2014 - 10:38am
tags:
InterMune

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.